Clinical trial
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
NCT00003175 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00003175 |
|---|---|
| Title | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer |
| Official title | A Phase II Study of Continuous 5-Fluorouracil (5-FU) in Recurrent Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urinary Tract |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil |
| Enrollment | 45 |
| Start date | Dec 1, 1997 |
| Completion | Mar 1, 2009 |
| First posted | Apr 30, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | Brazil, Canada, Finland, Netherlands, New Zealand, Norway, South Africa, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: